Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial.

J Clin Med · 2019 · PMC6617029 · PMID 31208060

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

A nonsignificant trend of fewer cases of new-onset preeclampsia and preeclampsia as the delivery indication in women treated with sildenafil was also reported in the NZAus STRIDER trial [ 23 ].

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.